Busca un médico

Charles Erlichman, M.D.

  1. Oncologist
Solicite una Consulta

Departamentos

Location

  1. Rochester, Minnesota

Idiomas

English

Pacientes existentes

  1. Cancer treatment
  • Multidisciplinary approach to laboratory studies of the pharmacology of drugs used in cancer therapy to the design and execution of clinical trials for cancer treatment
  1. 2099
    FellowAmerican College of Physicians
  2. 1980
    Visiting Fellow - Clinical PharmacologyNational Cancer Institute, National Institutes of Health
  3. 1978
    Chief Resident - Medical OncologyPrincess Margaret Hospital
  4. 1977
    Resident - Medical OncologyPrincess Margaret Hospital
  5. 1976
    Resident - MedicineToronto Western Hospital
  6. 1975
    Internship - MedicineMount Sinai Hospital
  7. 1974
    MDUniversity of Toronto
  8. 1971
    BScUniversity of Toronto

Certifications

  1. 1979
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2007
    Peter and Frances Georgeson Professorship in Gasteroentrology Cancer ResearchMayo Clinic
  2. 1979
    FellowshipMedical Research Council of Canada
  3. 1978
    FellowshipMedical Research Council of Canada
  4. 1973
    Mary H. Beatty Admission ScholarshipAwarding Organization
  5. 1972
    W. F. Watkins ScholarshipAwarding Organization
  6. 1972
    Mary H. Beatty Admission ScholarshipAwarding Organization
  7. 1971
    Medical Research Council GrantAwarding Organization
  8. 1971
    Mary H. Beatty Admission ScholarshipAwarding Organization
  9. 1970
    First Ann Shepard ScholarshipAwarding Organization
  10. 1970
    Mary H. Beatty Admission ScholarshipAwarding Organization
  11. 1969
    Third Ann Shepard ScholarshipAwarding Organization
  12. 1969
    Mary H. Beatty Admission ScholarshipAwarding Organization
  13. 1968
    Mary H. Beatty Admission ScholarshipAwarding Organization
  14. 1967
    Ontario Admission ScholarshipAwarding Organization
  15. 1967
    Mary H. Beatty Admission ScholarshipAwarding Organization

Professional memberships

  1. 2012 - present
    MemberSpecial Emphasis Panel (SEP) for the NCI Experimental Therapeutics (NExT) Program, National Cancer Institute of Canada
  2. 2011 - present
    Advisory Board MemberMarlene and Stewart Greenbaum Cancer Center External Advisory Committee (ESAC), University of Maryland
  3. 2010 - present
    MemberResearch Finance Committee, Mayo Clinic Rochester Committees
  4. 2010 - present
    MemberBiomarker Taskforce, Investigational Drug Steering Committee, National Cancer Institute
  5. 2010 - present
    MemberStem Cell Taskforce, Investigational Drug Steering Committee, National Cancer Institute
  6. 2009 - present
    MemberCommission of Cancer
  7. 2009 - present
    MemberCommitte of Health Professionals, with the American Hospital Association
  8. 2008 - 2010
    Co-ChairInvestigational Drug Steering Committee, National Cancer Institute, National Institutes of Health
  9. 2007 - 2009
    MemberFinance Committee - Rochester, Mayo Clinic Rochester Committees
  10. 2007 - present
    MemberIT Subcommittee, Research Committee, Mayo Clinic Rochester - Executive Board
  11. 2006
    MemberSpecial Review Committee to review GI SPORE grant applications, Bethesda, MD, National Cancer Institute, National Institutes of Health
  12. 2006 - 2007
    MemberBiomarker Taskforce, Investigational Drug Steering Committee, National Cancer Institute
  13. 2006
    MemberClinical Research Infrastructure Initiative, The Welcome Trust
  14. 2006
    MemberTemozolomide, Review of Product Development, Schering-Plough Research Institute
  15. 2005 - 2007
    Panel MemberSBIR/STTR grant panel, National Cancer Institute of Canada
  16. 2005
    Panel MemberSBIR/STTR grant panel, National Cancer Institute of Canada
  17. 2005 - 2007
    MemberInvestigational Drug Steering Committee, National Cancer Institute, National Institutes of Health
  18. 2005
    MemberScientific Advisory Board Cancer Chemotherapy Program Project, Memorial Sloan Kettering Cancer Center, Site Visit Team
  19. 2004
    MemberClinical and Companion Trials Panel, Ontario Cancer Research Network
  20. 2003 - present
    MemberMarketing Committee, Mayo Clinic Rochester Committees
  21. 2002 - 2003
    MemberPersonnel Committee - Rochester, Mayo Clinic Rochester Committees
  22. 2001 - 2004
    Associate DirectorTranslational Research, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  23. 2000 - 2003
    MemberVoluntary Review Board, Physician Data Query Protocols, National Cancer Institute
  24. 2000 - 2003
    MemberVoluntary Review Board, National Cancer Institute PDQ Protocols, National Cancer Institute of Canada
  25. 2000 - 2001
    Associate DirectorClinical Research Training Program
  26. 2000 - 2001
    MemberUniversity of Michigan Comprehensive Cancer Center, Site Visit Team, National Cancer Institute
  27. 1999
    MemberGrant Panel G, National Cancer Institute of Canada
  28. 1999
    MemberMemorial Sloan Kettering Cancer Center, Site Visit Team, National Cancer Institute
  29. 1999 - present
    MemberDivision of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics
  30. 1999 - present
    DirectorCancer Treatment, North Central Cancer Treatment Group, National Cancer Institute
  31. 1998 - 2001
    MemberNational Relations Committee, Mayo Clinic Rochester Committees
  32. 1998 - 2000
    MemberDialogue Advisory Board
  33. 1998
    MemberGrant Panel C, National Cancer Institute of Canada
  34. 1998
    MemberInternational Advisory Panel, SmithKline Beecham Pharmaceuticals
  35. 1997 - 1998
    MemberEducation Committee, American Association for Cancer Research
  36. 1997 - 1998
    MemberProgram Committee, American Association for Cancer Research
  37. 1997 - present
    MemberAudit and Finance Committee, American Society of Clinical Oncology
  38. 1997 - 2001
    Program LeaderClinical and Translational Research, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  39. 1997 - present
    MemberColorectal Cancer Advisory Group, American Cancer Society
  40. 1996 - 1997
    MemberProgram Committee, American Society of Clinical Oncology
  41. 1996 - present
    MemberExecutive Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  42. 1996 - present
    FellowAmerican College of Physicians
  43. 1996 - present
    MemberMedicine, Religion and Bioethics Committee, Zumbro Valley Medical Society, Minnesota Medical Association
  44. 1994 - 2002
    DirectorPhase I Study, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  45. 1994 - 1999
    Vice ChairOncology, General Clinical Research Center
  46. 1994 - 1999
    Vice ChairClinical Research Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  47. 1994 - 1997
    MemberData Safety Monitoring Board, Cancer and Leukemia Group B
  48. 1994 - present
    MemberOncology, General Clinical Research Center
  49. 1994 - present
    MemberClinical Research Executive Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  50. 1993
    MemberSpecial Review Committee, National Cancer Institute, National Institutes of Health
  51. 1992 - 1995
    MemberEducation Committee, American Society of Clinical Oncology
  52. 1992
    MemberSite Visit Team, Medicine Branch, National Cancer Institute
  53. 1992
    MemberMemorial Sloan Kettering Cancer Center, Site Visit Team, National Cancer Institute
  54. 1991
    ConsultantManitoba Cancer Treatment and Research Foundation
  55. 1991
    MemberSpecial Review Group, National Institutes of Health
  56. 1991 - 1993
    ChairGastrointestinal Site Group Committee, Princess Margaret Hospital
  57. 1991 - 1994
    ChairDrug Database Task Force, Princess Margaret Hospital
  58. 1991 - 1994
    MemberMedical Oncology Research Subcommittee, University of Toronto
  59. 1991 - 1992
    MemberProgram Committee, American Society of Clinical Oncology
  60. 1989 - 1994
    DirectorToronto Oncology Pharmacology Program, University of Toronto
  61. 1987 - 1991
    ChairPharmacy and Therapeutics Committee, Princess Margaret Hospital
  62. 1987 - 1993
    ChairmanG. I. Site Group Committee, National Cancer Institute of Canada
  63. 1987 - 1993
    ConsultantOntario Ministry of Health
  64. 1986 - 1991
    MemberSymptom Control Subcommitte, Princess Margaret Hospital
  65. 1985
    ChairAd Hoc Committee on Heroin Use, Princess Margaret Hospital
  66. 1985 - 1993
    MemberInvestigational New Drug Committee, National Cancer Institute of Canada
  67. 1985 - 1988
    MemberClinical Trials Committee, National Cancer Institute of Canada
  68. 1985 - 1994
    MemberUndergraduate Education Committee, Department of Pharmacology, University of Toronto
  69. 1984 - 1986
    MemberGrant Panel G, National Cancer Institute of Canada
  70. 1984 - 1987
    MemberPharmacy and Therapeutics Committee, Princess Margaret Hospital
  71. 1984 - 1987
    MemberQuality Assurance Committee, National Cancer Institute of Canada
  72. 1984 - 1990
    MemberClinical Pharmacology Postgraduate Training Committee, University of Toronto
  73. 1984 - 1985
    MemberOncology Curriculum Review Committee, University of Toronto
  74. 1983 - 1984
    ChairBiochemistry Users Subcommittee, Princess Margaret Hospital
  75. 1982 - 1984
    MemberGrant Panel C, National Cancer Institute of Canada
  76. 1982 - 1984
    MemberSymptom Control Subcommittee, Clinical Trials Committee, National Cancer Institute of Canada
  77. 1982 - 1984
    MemberClinical Pharmacology Committee, University of Toronto
  78. 1978 - 1980
    FellowMedical Research Council of Canada
  79. 1978 - present
    FellowRoyal College of Physicians of Canada
  80. 1975 - 2001
    MemberOntario College of Physicians and Surgeons
  81.  
    MemberDepartment of Internal Medicine
  82.  
    MemberOntario Medical Association
  83.  
    MemberCanadian Medical Association
  84.  
    MemberAmerican Society for Clinical Pharmacology and Therapeutics
  85.  
    MemberAmerican Medical Association
  86.  
    MemberAmerican Association for the Advancement of Science

Publications

Research activities

See a description of research activities.